Andrea Aroldi

8PUBLICATIONS
28CO-AUTHORS
Molecular targetsCancer diagnosisHaematological tumoursSequence analysisTransplantation immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 19, 2026
Palbociclib targets β-catenin for degradation and synergizes with KRAS or ERK5 inhibition in colorectal cancer preclinical models.

|Mar 13, 2025
Prognostic Biomarkers in Breast Cancer via Multi-Omics Clustering Analysis.

Federica Malighetti, Matteo Villa, Alberto Maria Villa

|Sep 01, 2023
Effects of blocking CD24 and CD47 'don't eat me' signals in combination with rituximab in mantle-cell lymphoma and chronic lymphocytic leukaemia.

Andrea Aroldi, Mario Mauri, Daniele Ramazzotti

|Jan 21, 2023
Characterization of SARS-CoV-2 Mutational Signatures from 1.5+ Million Raw Sequencing Samples.

Andrea Aroldi, Fabrizio Angaroni, Deborah D'Aliberti

|Dec 23, 2022
Post-Transplant Lymphoproliferative Disease (PTLD) after Allogeneic Hematopoietic Stem Cell Transplantation: Biology and Treatment Options.

Michele Clerico, Irene Dogliotti, Andrea Aroldi

|Oct 27, 2022
Advances and Hurdles in CAR T Cell Immune Therapy for Solid Tumors.

Francesco Boccalatte, Roberto Mina, Andrea Aroldi

Pageof 2

Frequent Collaborators

3 joint publications

Luca Mologni

3 joint publications

Rocco Piazza

3 joint publications

Carlo Gambacorti-Passerini

3 joint publications

Matteo Villa